Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial

BACKGROUND: Rezafungin (RZF) is a novel echinocandin exhibiting distinctive pharmacokinetics/pharmacodynamics. STRIVE was a phase 2, double-blind, randomized trial designed to compare the safety and efficacy of RZF once weekly (QWk) to caspofungin (CAS) once daily for treatment of candidemia and/or...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, George R, Soriano, Alex, Skoutelis, Athanasios, Vazquez, Jose A, Honore, Patrick M, Horcajada, Juan P, Spapen, Herbert, Bassetti, Matteo, Ostrosky-Zeichner, Luis, Das, Anita F, Viani, Rolando M, Sandison, Taylor, Pappas, Peter G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662762/
https://www.ncbi.nlm.nih.gov/pubmed/32955088
http://dx.doi.org/10.1093/cid/ciaa1380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662762/
https://www.ncbi.nlm.nih.gov/pubmed/32955088
http://dx.doi.org/10.1093/cid/ciaa1380

Ejemplares similares